An official website of the United States government
Figures & Tables — 2022 Viral Hepatitis Surveillance Report
Background
Hepatitis A
- Figure 1.1. Number of reported cases and estimated infections of hepatitis A — United States, 2015–2022
- Figure 1.2. Rates of reported cases of hepatitis A, by state or jurisdiction — United States, 2021–2022
- Figure 1.3. Rates of reported cases of hepatitis A, by state or jurisdiction — United States, 2022
- Figure 1.4. Rates of reported cases of hepatitis A, by age group — United States, 2007–2022
- Figure 1.5. Rates of reported cases of hepatitis A, by sex — United States, 2007–2022
- Figure 1.6. Rates of reported cases of hepatitis A, by race/ethnicity — United States, 2007–2022
- Figure 1.7. Availability of information regarding risk behaviors or exposures associated with reported cases of hepatitis A — United States, 2022
Hepatitis B
- Figure 2.1. Number of reported cases and estimated infections of acute hepatitis B — United States, 2015–2022
- Figure 2.2. Rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2021–2022
- Figure 2.3. Rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2022
- Figure 2.4. Rates of reported cases of acute hepatitis B, by age group — United States, 2007–2022
- Figure 2.5. Rates of reported cases of acute hepatitis B, by sex — United States, 2007–2022
- Figure 2.6. Rates of reported cases of acute hepatitis B, by race/ethnicity — United States, 2007–2022
- Figure 2.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis B — United States, 2022
- Figure 2.8. Rates of deaths with hepatitis B listed as a cause of death among residents, by state or jurisdiction — United States, 2022
Hepatitis C
- Figure 3.1. Number of reported cases and estimated infections of acute hepatitis C — United States, 2015–2022
- Figure 3.2. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2021–2022
- Figure 3.3. Rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2022
- Figure 3.4. Rates of reported cases of acute hepatitis C, by age group — United States, 2007–2022
- Figure 3.5. Rates of reported cases of acute hepatitis C, by sex — United States, 2007–2022
- Figure 3.6. Rates of reported cases of acute hepatitis C, by race/ethnicity — United States, 2007–2022
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C — United States, 2022
- Figure 3.8. Number of newly reported chronic hepatitis C cases by sex and age — United States, 2022
- Figure 3.9. Rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2022
Perinatal Hepatitis B Prevention Program
Hepatitis A
- Table 1.1. Numbers and rates of reported cases of hepatitis A, by state or jurisdiction — United States, 2018–2022
- Table 1.2. Numbers and rates of reported cases of hepatitis A, by demographic characteristics — United States, 2018–2022
- Table 1.3. Reported risk behaviors or exposures among reported cases of hepatitis A — United States, 2022
- Table 1.4. Numbers and rates of deaths with hepatitis A listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022
Hepatitis B
- Table 2.1. Numbers and rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2018–2022
- Table 2.2. Numbers and rates of reported cases of acute hepatitis B, by demographic characteristics — United States, 2018–2022
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B — United States, 2022
- Table 2.4. Number of newly reported cases of perinatal hepatitis B, by state or jurisdiction — United States, 2022
- Table 2.5. Number and rate of newly reported cases of chronic hepatitis B, by state or jurisdiction — United States, 2022
- Table 2.6. Number and rate of newly reported cases of chronic hepatitis B, by demographic characteristics — United States, 2022
- Table 2.7. Numbers and rates of deaths with hepatitis B listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 2.8. Numbers and rates of deaths with hepatitis B listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022
Hepatitis C
- Table 3.1. Numbers and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2018–2022
- Table 3.2. Numbers and rates of reported cases of acute hepatitis C, by demographic characteristics — United States, 2018–2022
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C — United States, 2022
- Table 3.4. Number of newly reported cases of perinatal hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C, by state or jurisdiction — United States, 2022
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C, by demographic characteristics — United States, 2022
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 3.8. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022
Perinatal Hepatitis B Prevention Program
Appendix
- Appendix Table 5.1. Number of reported cases and estimated infections of acute viral hepatitis with 95% bootstrap confidence intervals — United States, 2015–2022
- Appendix Table 5.2. Number of reported acute and chronic cases of hepatitis C by case status — United States, 2022
- Appendix Table 5.3. Numbers and rates of reported cases of acute hepatitis B and acute hepatitis C among adults aged 18–40 years old, by demographic characteristics — United States, 2022